UOC
AXGN icon

UBS O'Connor’s Axogen AXGN Stock Holding History

UBS O'Connor’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-81,429
Closed -$884K – 295
2025
Q2 		$884K Sell
81,429
-5,999
-7% -$78.6K 0.02% 238
2025
Q1 		$1.62M Sell
87,428
-53,000
-38% -$956K 0.04% 143
2024
Q4 		$2.31M Sell
140,428
-1,235
-0.9% -$17.5K 0.06% 140
2024
Q3 		$1.99M Buy
141,663
+4,088
+3% +$45.2K 0.05% 173
2024
Q2 		$996K Hold
137,575
– – 0.03% 296
2024
Q1 		$1.11M Hold
137,575
– – 0.03% 264
2023
Q4 		$940K Sell
137,575
-101,621
-42% -$565K 0.03% 278
2023
Q3 		$1.2M Sell
239,196
-37,387
-14% -$259K 0.02% 311
2023
Q2 		$2.53M Buy
276,583
+17,369
+7% +$162K 0.05% 225
2023
Q1 		$2.45M Buy
+259,214
New +$2.37M 0.06% 246
2022
Q4 		– Sell
-225,477
Closed -$2.69M – 44
2022
Q3 		$2.69M Buy
225,477
+40,000
+22% +$400K 0.03% 476
2022
Q2 		$1.52M Buy
+185,477
New +$1.59M 0.02% 711

Other funds holding AXGN

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

UBS O'Connor's AXGN Position: Q3 2025 in Review

UBS O'Connor sold out of Axogen (AXGN) in Q3 2025, closing a stake of 81,429 shares — an estimated $884K sold.

UBS O'Connor first reported a position in AXGN in Q2 2022 and held it in 12 quarters. The position peaked at $2.69M in Q3 2022. 171 funds tracked by Wall St. Rank hold AXGN as of Q3 2025.

  • UBS O'Connor reported no remaining Axogen position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 81,429 Axogen shares in Q3 2025, an estimated $884K.
  • UBS O'Connor first reported a position in Axogen in Q2 2022 and held it in 12 quarters.
  • UBS O'Connor's Axogen position peaked at $2.69M in Q3 2022.
  • 171 funds tracked by Wall St. Rank held Axogen as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.